Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
John H. Alexander
ResearcherPublications, citations & collaboration network
John H. Alexander is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 786 works, 45,215 citations, an h-index of 106 and an i10-index of 364.
786
Works
45,215
Citations
106
h-index
364
i10-index
How has John H. Alexander's publication output changed over time?
ScholarIQpublication output · 2011–2025
Output declined50% over the shown period — from 2 works in 2011 to 1 in 2025.
2
1
1
1
1
1
4
1
20112012201620172018201920212025
What are the most-cited papers on John H. Alexander?
ScholarIQmost cited works
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray, Renato D. Lópes, Elaine M. Hylek, Michael G. Hanna, Hussein R. Al‐Khalidi, Jack Ansell, Dan Atar, Álvaro Avezum, M. Cecilia Bahit, Rafael Díaz, J. Donald Easton, Justin A. Ezekowitz, Greg Flaker, David García, Margarida Geraldes, Bernard J. Gersh, Golitsyn Sp, Shinya Goto, Antonio G. Hermosillo, Stefan H. Hohnloser, John D. Horowitz, Puneet Mohan, Petr Janský, Basil S. Lewis, José López‐Sendón, Prem Pais, Alexander Parkhomenko, Freek W.A. Verheugt, Jun Zhu, Lars Wallentin
New England Journal of Medicine. 20118,956 CitationsOPEN ACCESS
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D. Lópes, Gretchen Heizer, Ronald Aronson, Amit N. Vora, Tyler Massaro, Roxana Mehran, Shaun G. Goodman, Stephan Windecker, Harald Darius, Jia Li, О. В. Аверков, M. Cecilia Bahit, Otávio Berwanger, Andrzej Budaj, Ziad Hijazi, Alexander Parkhomenko, Peter Sinnaeve, Robert F. Storey, Hölger Thiele, Dragoş Vinereanu, Christopher B. Granger, John H. Alexander
New England Journal of Medicine. 20191,200 CitationsOPEN ACCESS
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E. Cooper, Steven E. Kahn, Nikolaus Marx, John H. Alexander, Michael Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, Hans J. Woerle, David Baanstra, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, for the CARMELINA Investigators
JAMA. 20181,089 CitationsOPEN ACCESS
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
John H. Alexander, Renato D. Lópes, Stefan James, Rakhi Kilaru, Yaohua He, Puneet Mohan, Deepak L. Bhatt, Shaun G. Goodman, Freek W.A. Verheugt, Marcus Flather, Kurt Huber, Danny Liaw, Steen Husted, José López‐Sendón, Raffaele De Caterina, Petr Janský, Harald Darius, Dragoş Vinereanu, Jan H. Cornel, Frank Cools, Dan Atar, José L. Leiva-Pons, Mátyás Keltai, Hisao Ogawa, Prem Pais, Alexander Parkhomenko, Witold Rużyłło, Rafael Díaz, Harvey D. White, Mikhail Ruda, Margarida Geraldes, Jack Lawrence, Robert A. Harrington, Lars Wallentin
New England Journal of Medicine. 2011998 CitationsOPEN ACCESS
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
Stefan H. Hohnloser, Ziad Hijazi, Laine Thomas, John H. Alexander, John Amerena, Michael G. Hanna, Mátyás Keltai, Fernando Laņas, Renato D. Lópes, José López‐Sendón, Christopher B. Granger, Lars Wallentin
European Heart Journal. 2012574 CitationsOPEN ACCESS
Related on ScholarIQ
Ohio State University Hospital
Institution
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Paper
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Paper
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
Paper
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
Paper
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
Paper